Press Releases

WESTBURY, NY - May 17, 2017 - BioreclamationIVT, a leading provider of biospecimens and related services, today announced that it has appointed Lauren Vagnone as senior marketing communications manager. In this newly-created position, Ms. Vagnone will be responsible for leading BioreclamationIVT’s communications campaigns and raising awareness of its product portfolio in the life sciences industry.

BioreclamationIVT provides biopharmaceutical companies with specialized in vitro products and services for studying drug metabolism, drug-drug interactions, and toxicity responses to expedite new drug and diagnostic development.

“We enable disease researchers to generate more relevant data faster so that their research is more productive and cost-effective,” said BioreclamationIVT Vice President of Marketing Courtney Noah, PhD. “All BioreclamationIVT products are derived from primary sources, ensuring that our customers are investigating cell lines directly and not using surrogates that may have changed over time. Therefore, the results we generate are closer to an in vivo response.”

“I am excited to join the BioreclamationIVT team as it starts to impact all stages of the drug development process from discovery right through to patient care,” said Ms. Vagnone.

Ms. Vagnone previously served as senior manager of corporate marketing for RR Donnelly, a global integrated communications provider. Prior to that, she was trade marketing manager for Super Enterprises, and marketing manager for Speco Technologies. She brings extensive go-to-market strategy development, and sales enablement experience to her new role.

Ms. Vagnone has a bachelor’s degree in journalism with an emphasis in marketing from Hofstra University.

About BioreclamationIVT
BioreclamationIVT is a worldwide provider of biological products to the life sciences and pharmaceutical industries. BioreclamationIVT specializes in control and disease-state matrices manufactured from human and animal biological specimens and has recently expanded its offering to include cell processing and phenotypic screening services. This portfolio of products is utilized throughout the drug discovery and development research workflows, and directly supports the Precision Medicine Initiative by coupling clinical information with numerous disease-state fluids and tissues. BioreclamationIVT’s reputation for providing exceptional customer service coupled with the highest quality specimens and services have made it the first-choice supplier for biospecimens for more than 35 years. For more information, please visit www.bioreclamationivt.com.